Ignite Creation Date:
2025-12-24 @ 2:46 PM
Ignite Modification Date:
2026-01-04 @ 2:01 PM
Study NCT ID:
NCT00857259
Status:
TERMINATED
Last Update Posted:
2011-08-19
First Post:
2009-03-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration
Sponsor:
Novartis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CRAD001A2203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
External Affairs
Old Organization:
Novartis Pharmaceuticals